Form 4: Fulgent Genetics CFO Paul Kim Reports Tax-Related Stock Transaction
SEC Form 4 Filing
Paul Kim, CFO and Treasurer of Fulgent Genetics, reports the withholding of 1,412 shares of common stock to cover tax obligations arising from vesting restricted stock units.
Summary
- On May 3, 2024, Paul Kim, CFO and Treasurer of Fulgent Genetics, Inc., had 1,412 shares of common stock withheld to satisfy tax obligations.
- This transaction occurred due to the vesting of restricted stock units granted on August 3, 2020.
- Following the transaction, Kim directly owns 218,260 shares of Fulgent Genetics common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a routine stock transaction for tax purposes. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common among publicly traded companies. It provides transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a routine tax-related stock withholding.
Key Dates
| Date | Description |
|---|---|
| 08/03/2020 | Date of original grant of restricted stock units. |
| 08/05/2020 | Date Form 4 was filed with the SEC reporting the grant of restricted stock units. |
| 05/03/2024 | Date of the stock withholding transaction for tax obligations. |
| 05/07/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.